tebuquine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2009
01219862009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Amodiaquine is a 4-aminoquinoline antimalarial that can cause adverse side effects including hepatic and haematological toxicity… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
To develop new classes of antimalarial agents, the possibility of replacing the phenolic ring of amodiaquine, tebuquine, and… (More)
Is this relevant?
2007
2007
Amodiaquine (AQ) and tebuquine are 4-aminoquinoline antimalarials with Mannich base side chain and are highly effective against… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
Tebuquine is a 4-aminoquinoline that shows significantly more potency as an antimalarial than amodiaquine and chloroquine both in… (More)
Is this relevant?
1998
1998
Life-threatening agranulocytosis and hepatotoxicity during prophylactic administration of amodiaquine have led to its withdrawal… (More)
Is this relevant?
1998
1998
The use of the antimalarial agent amodiaquine has been curtailed due to drug-induced idiosyncratic reactions. These have been… (More)
Is this relevant?
1997
1997
Tebuquine (5) is a 4-aminoquinoline that is significantly more active than amodiaquine (2) and chloroquine (1) both in vitro and… (More)
Is this relevant?
1986
1986
A series of 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl] [1,1'-biphenyl]-2-ols and N omega-oxides was prepared from… (More)
Is this relevant?